BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1303275)

  • 21. No mutation in codon 713 of the amyloid precursor gene in schizophrenic patients.
    Carter D; Campion D; d'Amato T; Jay M; Brice A; Bellis M; Mallet J; Agid Y
    Hum Mol Genet; 1993 Mar; 2(3):321. PubMed ID: 8499923
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of amyloid beta-protein precursor mRNAs in cultured skin fibroblasts taken from patients with dementia of the Alzheimer type.
    Okada A; Urakami K; Takahashi K; Ohno K; Sato K; Endo H
    Dementia; 1994; 5(1):55-6. PubMed ID: 8156089
    [No Abstract]   [Full Text] [Related]  

  • 23. Reported sequence homology between Alzheimer amyloid770 and the MRC OX-2 antigen does not predict function.
    Richards SJ; Hodgman C; Sharpe M
    Brain Res Bull; 1995; 38(3):305-6. PubMed ID: 7496825
    [No Abstract]   [Full Text] [Related]  

  • 24. Abnormalities of amyloid beta precursor protein expression in platelets of patients with Alzheimer disease: do we understand them well enough?
    Blasko I; Marx F; Grubeck-Loebenstein B; Marksteiner J
    Arch Neurol; 1999 Jul; 56(7):889-91. PubMed ID: 10404994
    [No Abstract]   [Full Text] [Related]  

  • 25. AbetaPP A713T mutation in late onset Alzheimer's disease with cerebrovascular lesions.
    Bernardi L; Geracitano S; Colao R; Puccio G; Gallo M; Anfossi M; Frangipane F; Curcio SA; Mirabelli M; Tomaino C; Vasso F; Smirne N; Maletta R; Bruni AC
    J Alzheimers Dis; 2009; 17(2):383-9. PubMed ID: 19363265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.
    Conidi ME; Bernardi L; Puccio G; Smirne N; Muraca MG; Curcio SA; Colao R; Piscopo P; Gallo M; Anfossi M; Frangipane F; Clodomiro A; Mirabelli M; Vasso F; Cupidi C; Torchia G; Di Lorenzo R; Mandich P; Confaloni A; Maletta RG; Bruni AC
    Neurology; 2015 Jun; 84(22):2266-73. PubMed ID: 25948718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene.
    Rossi G; Giaccone G; Maletta R; Morbin M; Capobianco R; Mangieri M; Giovagnoli AR; Bizzi A; Tomaino C; Perri M; Di Natale M; Tagliavini F; Bugiani O; Bruni AC
    Neurology; 2004 Sep; 63(5):910-2. PubMed ID: 15365148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease.
    Wakutani Y; Watanabe K; Adachi Y; Wada-Isoe K; Urakami K; Ninomiya H; Saido TC; Hashimoto T; Iwatsubo T; Nakashima K
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1039-42. PubMed ID: 15201367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
    Kamino K; Orr HT; Payami H; Wijsman EM; Alonso ME; Pulst SM; Anderson L; O'dahl S; Nemens E; White JA
    Am J Hum Genet; 1992 Nov; 51(5):998-1014. PubMed ID: 1415269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical considerations in early-onset cerebral amyloid angiopathy.
    Banerjee G; Collinge J; Fox NC; Lashley T; Mead S; Schott JM; Werring DJ; Ryan NS
    Brain; 2023 Oct; 146(10):3991-4014. PubMed ID: 37280119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare Amyloid Precursor Protein Point Mutations Recapitulate Worldwide Migration and Admixture in Healthy Individuals: Implications for the Study of Neurodegeneration.
    Abondio P; Bruno F; Bruni AC; Luiselli D
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Potential Roles of Redox Enzymes in Alzheimer's Disease: Focus on Thioredoxin.
    Jia J; Zeng X; Xu G; Wang Z
    ASN Neuro; 2021; 13():1759091421994351. PubMed ID: 33557592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Customized Next-Generation Sequencing-Based Panel to Identify Novel Genetic Variants in Dementing Disorders: A Pilot Study.
    Lanza G; Calì F; Vinci M; Cosentino FII; Tripodi M; Spada RS; Cantone M; Bella R; Mattina T; Ferri R
    Neural Plast; 2020; 2020():8078103. PubMed ID: 32908482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.
    Peng Y; Gao P; Shi L; Chen L; Liu J; Long J
    Antioxid Redox Signal; 2020 Jun; 32(16):1188-1236. PubMed ID: 32050773
    [No Abstract]   [Full Text] [Related]  

  • 35. Bridging Genomics to Phenomics at Atomic Resolution through Variation Spatial Profiling.
    Wang C; Balch WE
    Cell Rep; 2018 Aug; 24(8):2013-2028.e6. PubMed ID: 30134164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early onset Alzheimer's disease and oxidative stress.
    Meraz-Ríos MA; Franco-Bocanegra D; Toral Rios D; Campos-Peña V
    Oxid Med Cell Longev; 2014; 2014():375968. PubMed ID: 24669286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular determinants and thermodynamics of the amyloid precursor protein transmembrane domain implicated in Alzheimer's disease.
    Wang H; Barreyro L; Provasi D; Djemil I; Torres-Arancivia C; Filizola M; Ubarretxena-Belandia I
    J Mol Biol; 2011 May; 408(5):879-95. PubMed ID: 21440556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence from solid-state NMR for nonhelical conformations in the transmembrane domain of the amyloid precursor protein.
    Lu JX; Yau WM; Tycko R
    Biophys J; 2011 Feb; 100(3):711-719. PubMed ID: 21281586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
    Rostagno A; Holton JL; Lashley T; Revesz T; Ghiso J
    Cell Mol Life Sci; 2010 Feb; 67(4):581-600. PubMed ID: 19898742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.